The Neuro - Profile: Boris Bernhardt

Boris Bernhardt wins CAN's 2022 New Investigator Award

��VR��Ƶ — Tue, 12 Apr 2022 19:10:12 +0000

Together with Dr. Birgit Frauscher, Bernhardt co-directs The Neuro’s new Centre of Excellence in Epilepsy

Since joining The Neuro in 2016, Boris Bernhardt, PhD, Assistant Professor of Neurology and Neurosurgery, has published pioneering research on the organization and development of the healthy brain. His achievements have been recognized this week by the Canadian Association for Neuroscience, who have awarded him the 2022 New Investigator Award.

Big data analysis suggests role of brain connectivity in epilepsy-related atrophy

��VR��Ƶ — Wed, 02 Dec 2020 14:35:12 +0000

Large multi-site study accurately predicts damage to grey matter by disease

An international study has found a link between the brain’s network connections and grey matter atrophy caused by certain types of epilepsy, a major step forward in our understanding of the disease.

Four early-career researchers receive leadership grants

��VR��Ƶ — Mon, 09 Nov 2020 19:36:34 +0000

Brain Canada program supports paradigm-shifting neuroscience that improves the lives of Canadians

Four researchers at The Neuro — Boris Bernhardt, Yasser Iturria-Medina, Jean-Francois Poulin, and Jo Anne Stratton — have received grants to support their work in the early-career stage, after being chosen from 150 talented applicants.

Brain Canada’s Future Leaders in Canadian Brain Research Program, anchored by a $5M gift from the Azrieli Foundation, enables paradigm-changing research of the brain to improve the lives of all Canadians.

Epilepsy research and care at The Neuro

��VR��Ƶ — Fri, 23 Mar 2018 14:20:45 +0000

The institute that developed the “Montreal Procedure” continues to be on the cutting edge

The Neuro is recognized worldwide as a leader in epilepsy research and treatment. From the beginning, Neuro founder, Dr. Wilder Penfield, made epilepsy a central focus. He and his colleagues developed a surgical treatment for epilepsy patients known as the “Montreal Procedure,” which today is in use throughout the world. The Neuro became a pioneer in studying epilepsy through the use of electroencephalography (EEG) and magnetic resonance imaging (MRI).

Epilepsy Day 2017

��VR��Ƶ — Wed, 15 Mar 2017 19:13:36 +0000

March 26 is Purple Day for Epilepsy, a day to support epilepsy awareness worldwide

The Neuro has been a world leader in epilepsy treatment and research for more than 60 years. Indeed, the “Montreal Procedure” developed by The Neuro’s founder, Dr. Wilder Penfield, and his colleagues has become the standard operating procedure for the surgical treatment of epilepsy. The Neuro was also a pioneering institute in exploiting electroencephalography (EEG) and magnetic resonance imaging (MRI) to study and treat epilepsy.